Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Wyc-210 | 2131803-93-3 | 99.2% | 340.40 | 50 MG
Supplier: Medchemexpress LLC HY13655450MG
WYC-210 is a retinoid compound that is a derivative of Tazarotene and exhibits lower anticancer activity. This compound functions as a click chemistry reagent, featuring an Alkyne group that enables it to undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) when combined with molecules containing Azide groups.
- Retinoid compound: a derivative of Tazarotene.
- Lower anticancer activity: demonstrates reduced activity compared to its parent compound.
- Click chemistry reagent: contains an Alkyne group.
- CuAAc compatibility: capable of undergoing copper-catalyzed azide-alkyne cycloaddition with azide-containing molecules.
- Inhibits cell growth: at a concentration of 10 μM over 5 days, it inhibits the cell growth of B16-F1 TRC cells by 18.1%.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?